199 related articles for article (PubMed ID: 27667443)
1. Human and mouse monocytes display distinct signalling and cytokine profiles upon stimulation with FFAR2/FFAR3 short-chain fatty acid receptor agonists.
Ang Z; Er JZ; Tan NS; Lu J; Liou YC; Grosse J; Ding JL
Sci Rep; 2016 Sep; 6():34145. PubMed ID: 27667443
[TBL] [Abstract][Full Text] [Related]
2. FFAR2-FFAR3 receptor heteromerization modulates short-chain fatty acid sensing.
Ang Z; Xiong D; Wu M; Ding JL
FASEB J; 2018 Jan; 32(1):289-303. PubMed ID: 28883043
[TBL] [Abstract][Full Text] [Related]
3. GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes.
Nøhr MK; Pedersen MH; Gille A; Egerod KL; Engelstoft MS; Husted AS; Sichlau RM; Grunddal KV; Poulsen SS; Han S; Jones RM; Offermanns S; Schwartz TW
Endocrinology; 2013 Oct; 154(10):3552-64. PubMed ID: 23885020
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of free fatty acid receptors FFAR2 and FFAR3 in the domestic cat.
Yamamoto I; Kawasumi K; Ohkusu-Tsukada K; Arai T
Vet Med Sci; 2021 Jan; 7(1):77-85. PubMed ID: 32929853
[TBL] [Abstract][Full Text] [Related]
5. Lung immune tone via gut-lung axis: gut-derived LPS and short-chain fatty acids' immunometabolic regulation of lung IL-1β, FFAR2, and FFAR3 expression.
Liu Q; Tian X; Maruyama D; Arjomandi M; Prakash A
Am J Physiol Lung Cell Mol Physiol; 2021 Jul; 321(1):L65-L78. PubMed ID: 33851870
[TBL] [Abstract][Full Text] [Related]
6. Free fatty acids receptors 2 and 3 control cell proliferation by regulating cellular glucose uptake.
Al Mahri S; Al Ghamdi A; Akiel M; Al Aujan M; Mohammad S; Aziz MA
World J Gastrointest Oncol; 2020 May; 12(5):514-525. PubMed ID: 32461783
[TBL] [Abstract][Full Text] [Related]
7. Short Chain Fatty Acids Enhance Expression and Activity of the Umami Taste Receptor in Enteroendocrine Cells via a Gα
Shackley M; Ma Y; Tate EW; Brown AJH; Frost G; Hanyaloglu AC
Front Nutr; 2020; 7():568991. PubMed ID: 33195366
[TBL] [Abstract][Full Text] [Related]
8. Free Fatty Acid Receptors 2 and 3 as Microbial Metabolite Sensors to Shape Host Health: Pharmacophysiological View.
Mishra SP; Karunakar P; Taraphder S; Yadav H
Biomedicines; 2020 Jun; 8(6):. PubMed ID: 32521775
[TBL] [Abstract][Full Text] [Related]
9. Short-chain fatty acids: possible regulators of insulin secretion.
Rosli NSA; Abd Gani S; Khayat ME; Zaidan UH; Ismail A; Abdul Rahim MBH
Mol Cell Biochem; 2023 Mar; 478(3):517-530. PubMed ID: 35943655
[TBL] [Abstract][Full Text] [Related]
10. Effects of free fatty acid receptor-2 (FFAR2)-mediated signaling on the regulation of cellular functions in osteosarcoma cells.
Kurisu R; Takai M; Takamoto M; Tsujiuchi T
Biochem Biophys Res Commun; 2023 Feb; 646():56-62. PubMed ID: 36706706
[TBL] [Abstract][Full Text] [Related]
11. FFAR2 antagonizes TLR2- and TLR3-induced lung cancer progression via the inhibition of AMPK-TAK1 signaling axis for the activation of NF-κB.
Kim MJ; Kim JY; Shin JH; Kang Y; Lee JS; Son J; Jeong SK; Kim D; Kim DH; Chun E; Lee KY
Cell Biosci; 2023 Jun; 13(1):102. PubMed ID: 37287005
[TBL] [Abstract][Full Text] [Related]
12. Expression of the short chain fatty acid receptor GPR41/FFAR3 in autonomic and somatic sensory ganglia.
Nøhr MK; Egerod KL; Christiansen SH; Gille A; Offermanns S; Schwartz TW; Møller M
Neuroscience; 2015 Apr; 290():126-37. PubMed ID: 25637492
[TBL] [Abstract][Full Text] [Related]
13. Effect of short chain fatty acids on the expression of free fatty acid receptor 2 (Ffar2), Ffar3 and early-stage adipogenesis.
Frost G; Cai Z; Raven M; Otway DT; Mushtaq R; Johnston JD
Nutr Diabetes; 2014 Aug; 4(8):e128. PubMed ID: 25089883
[TBL] [Abstract][Full Text] [Related]
14. Impaired gut barrier integrity and reduced colonic expression of free fatty acid receptors in patients with Parkinson's disease.
Liao PH; Tung HY; Lim WS; Jang JR; Li H; Shun CT; Chiu HM; Wu MS; Lin CH
Neurol Sci; 2024 Jun; ():. PubMed ID: 38862654
[TBL] [Abstract][Full Text] [Related]
15. Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity.
Remely M; Aumueller E; Merold C; Dworzak S; Hippe B; Zanner J; Pointner A; Brath H; Haslberger AG
Gene; 2014 Mar; 537(1):85-92. PubMed ID: 24325907
[TBL] [Abstract][Full Text] [Related]
16. Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet.
Bjursell M; Admyre T; Göransson M; Marley AE; Smith DM; Oscarsson J; Bohlooly-Y M
Am J Physiol Endocrinol Metab; 2011 Jan; 300(1):E211-20. PubMed ID: 20959533
[TBL] [Abstract][Full Text] [Related]
17. Participation of Short-Chain Fatty Acids and Their Receptors in Gut Inflammation and Colon Cancer.
Carretta MD; Quiroga J; López R; Hidalgo MA; Burgos RA
Front Physiol; 2021; 12():662739. PubMed ID: 33897470
[TBL] [Abstract][Full Text] [Related]
18. The short-chain fatty acid butyrate exerts a specific effect on VE-cadherin phosphorylation and alters the integrity of aortic endothelial cells.
Guo J; Terhorst I; Stammer P; Ibrahim A; Oberhuber A; Eierhoff T
Front Cell Dev Biol; 2023; 11():1076250. PubMed ID: 36846596
[TBL] [Abstract][Full Text] [Related]
19. Free fatty acid receptor 2, a candidate target for type 1 diabetes, induces cell apoptosis through ERK signaling.
Shi G; Sun C; Gu W; Yang M; Zhang X; Zhai N; Lu Y; Zhang Z; Shou P; Zhang Z; Ning G
J Mol Endocrinol; 2014 Dec; 53(3):367-80. PubMed ID: 25298143
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of chemokine production by Fcgamma receptor engagement in human monocytes: association of CCL1 with a distinct form of M2 monocyte activation (M2b, Type 2).
Sironi M; Martinez FO; D'Ambrosio D; Gattorno M; Polentarutti N; Locati M; Gregorio A; Iellem A; Cassatella MA; Van Damme J; Sozzani S; Martini A; Sinigaglia F; Vecchi A; Mantovani A
J Leukoc Biol; 2006 Aug; 80(2):342-9. PubMed ID: 16735693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
